Poor efficacy of the combination of clarithromycin, amikacin, and cefoxitin against Mycobacterium abscessus in the hollow fiber infection model

Abstract Background Mycobacterium abscessus (MABS) causes difficult-to-treat pulmonary and extra-pulmonary infections. A combination therapy comprising amikacin, cefoxitin, and a macrolide agent is recommended, but its antimicrobial activity and clinical efficacy is uncertain. Inducible resistance t...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Annals of Clinical Microbiology and Antimicrobials
المؤلفون الرئيسيون: Etienne Vignaud, Sylvain Goutelle, Charlotte Genestet, Jérôme Guitton, Sabine Cohen, Chloé Bourg, Aurore Durand, Laura Lebouteiller, Albin Bernard, Caroline Richet, Oana Dumitrescu, Elisabeth Hodille
التنسيق: مقال
اللغة:الإنجليزية
منشور في: BMC 2025-01-01
الموضوعات:
Mycobacterium abscessus
Hollow-fiber system
Hollow-fiber infection model
Clarithromycin
Amikacin
Cefoxitin
الوصول للمادة أونلاين:https://doi.org/10.1186/s12941-025-00776-w

الانترنت

https://doi.org/10.1186/s12941-025-00776-w

مواد مشابهة